A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients.

A Comparative Study on the Efficacy of Blue Light Emitting Diodes Therapy Versus Targeted Narrow Band UVB in Stable Non-segmental Vitiligo Patients.

A comparative study on the efficacy of blue light emitting diodes therapy versus targeted Narrow band UVB in stable non-segmental vitiligo patients.

A comparative study on the efficacy of blue light emitting diodes therapy versus targeted Narrow band UVB in stable non-segmental vitiligo patients.

Inclusion Criteria:

• All age group.

  • Both genders.
  • Subjects with stable non-segmental vitiligo (≥2 patches) acral or non-acral patches of diameter ≤ 2cm.

Exclusion Criteria:

• Prior treatment with laser therapies for at least 3 months

  • Recent exfoliation procedures.
  • Recent surgical procedures.
  • Poor skin conditions including keloids.
  • Hypersensitivity to light ( visible and near-infrared).
  • Medications that make users more sensitive to light.
  • Anticoagulant and immunosuppressive treatments.
  • Gestations or breastfeeding.
  • A personal or family history of skin cancer.
  • Unstable vitiligo (older lesions have not progressed for the last 1 years and lack of Koebner phenomena ).